U.S. Wireless Telecom Stock News

NasdaqGS:KTOS
NasdaqGS:KTOSAerospace & Defense

Why Kratos (KTOS) Is Down 9.6% After Raising Its 2026 Outlook And Expanding Backlog

In early May 2026, Kratos Defense & Security Solutions reported first-quarter 2026 revenue of US$371.0 million and net income of US$11.9 million, then raised its full-year 2026 outlook to US$1.70 billion–US$1.76 billion in revenue and US$18 million–US$23 million in operating income, including contributions from recent Nomad and Orbit Technologies acquisitions. Management also projected much stronger second-half 2026 activity tied to hypersonics, unmanned systems, missile and space programs,...
NasdaqGS:SYNA
NasdaqGS:SYNASemiconductor

Synaptics (SYNA) Q2 Loss Of US$0.38 EPS Tests Profitability Turnaround Narrative

Synaptics (SYNA) has posted Q2 2026 results with revenue of US$302.5 million and a basic EPS loss of US$0.38, alongside trailing 12 month revenue of US$1.1 billion and a basic EPS loss of US$1.59. This keeps the focus firmly on how fast profitability can improve from here. Over the past six reported quarters, revenue has moved from US$257.7 million in Q1 2025 to US$302.5 million in Q2 2026. Over the same period, quarterly basic EPS has ranged from a loss of US$0.58 to a loss of US$0.12 and...
NYSE:RBC
NYSE:RBCMachinery

A Look At RBC Bearings (RBC) Valuation After Backlog And Aerospace Defense Growth Fuel Outperformance

RBC Bearings (RBC) is back in focus after a series of investor letters credited the stock with strong recent contributions, pointing to aerospace and defense strength, content gains, and a record backlog. See our latest analysis for RBC Bearings. The recent all time high near the current US$611.54 share price caps a strong run, with a year to date share price return of 33.29% and a 1 year total shareholder return of 75.13%. This suggests momentum has been building as aerospace and defense...
NYSE:MDU
NYSE:MDUGas Utilities

MDU Resources Group (MDU) Valuation After Q1 2026 Earnings Miss And Bakken East Pipeline Progress

MDU Resources Group (MDU) shares were in focus after first quarter 2026 earnings came in below analyst expectations, even as management reaffirmed full year earnings guidance and detailed progress on the proposed Bakken East pipeline project. See our latest analysis for MDU Resources Group. The stock has been firming up despite the Q1 earnings miss, with a 30 day share price return of 4.08%, a 90 day gain of 10.47%, and a 1 year total shareholder return of 32.33% that reflects interest in...
NasdaqGS:TRS
NasdaqGS:TRSPackaging

A Look At TriMas (TRS) Valuation After Guidance Reaffirmation Results And New Dividend

Why TriMas (TRS) is back on investors’ radar TriMas (TRS) just paired reaffirmed 2026 guidance with first quarter results, a buyback update and a fresh dividend, giving you a dense set of signals to reassess the stock. This cluster of events, along with leadership focused on standardization and integrating recent packaging acquisitions, has arrived alongside a 15.33% 7 day share price return and renewed interest in TriMas. See our latest analysis for TriMas. The reaffirmed 2026 guidance,...
NYSE:DRD
NYSE:DRDMetals and Mining

A Look At DRDGOLD (NYSE:DRD) Valuation After A Strong Quarter Of Higher Gold Prices And Output

Quarterly update and why it matters for DRDGOLD (DRD) DRDGOLD (DRD) reported a stronger quarter to 31 March 2026, with revenue up 6% as higher Rand gold prices and a 6% lift in production improved cash generation and Adjusted EBITDA. See our latest analysis for DRDGOLD. The latest quarterly update comes after a mixed price pattern, with a 5.19% 7 day share price return but a 13.37% 90 day share price decline. The 1 year total shareholder return of 94.98% and 5 year total shareholder return of...
NYSE:COR
NYSE:CORHealthcare

Can Cencora (COR) Sustain Its Margin Gains While Accepting Slower Revenue Growth?

Cencora, Inc. has already reported fiscal 2026 second-quarter results, posting sales of US$78.36 billion and net income of US$1.64 billion, while slightly raising adjusted EPS guidance but trimming full-year revenue growth expectations to a 4%–6% range. The quarter highlighted improving profitability helped by the OneOncology acquisition and margin expansion, even as U.S. Healthcare Solutions faced headwinds from pricing pressure, customer mix shifts and slower growth in key drug...
NYSE:PVH
NYSE:PVHLuxury

Is the G-III Licensing Fight Reshaping the Earnings Quality Narrative for PVH (PVH)?

PVH Corp. previously declared a quarterly dividend of US$0.0375 per share, payable on June 24, 2026, with both ex-dividend and record dates on June 3, 2026, while confronting higher oil-driven supply chain costs and pressure on margins across the apparel sector. At the same time, PVH’s intensifying legal dispute with G-III over Calvin Klein and Tommy Hilfiger licenses, alongside concerns about debt and foreign-exchange-driven growth, raises fresh questions about the resilience and quality of...
NYSE:CMI
NYSE:CMIMachinery

Does Cummins’ Data Center Boost And Guidance Hike Change The Bull Case For CMI?

Cummins Inc. recently reported first-quarter 2026 results showing sales of US$8,398 million versus US$8,174 million a year earlier, with net income of US$654 million, and raised its full-year 2026 revenue guidance to an 8%–11% increase on stronger North American on-highway and power generation demand. The company’s Power Systems segment is benefiting from heightened data center power needs while exiting its low-pressure fuel cell business, sharpening its focus on higher-return zero-emission...
NasdaqGS:BCRX
NasdaqGS:BCRXBiotechs

Is BioCryst Pharmaceuticals (BCRX) Pricing Reflect Its Pipeline Progress And Recent Share Performance Changes

If you are wondering whether BioCryst Pharmaceuticals, at a last close of US$8.90, still offers value, it helps to step back and look at the full valuation picture rather than just the recent share price. The stock is up 18.7% year to date, although it has seen a 2.8% decline over the last week and a 7.2% decline over the last month, and the 1 year return sits at a 10.3% decline. Recent news coverage has focused on BioCryst Pharmaceuticals' pipeline progress and its positioning within the...
NYSE:CAG
NYSE:CAGFood

Large SNAP Cuts and Policy Shifts Might Change The Case For Investing In Conagra Brands (CAG)

The US House previously passed a farm bill that includes a very large US$187 billion reduction to SNAP, alongside updates to crop insurance and commodity price supports that could reshape food assistance and agricultural markets for companies like Conagra Brands. At the same time, Conagra’s new Citizenship Report and updated bylaws highlight its focus on sustainability and shareholder engagement just as major policy changes introduce fresh demand uncertainty. We’ll now examine how this very...
NasdaqGS:NXT
NasdaqGS:NXTElectrical

Nextpower’s New Legal Chief Puts Policy And ESG Focus In Spotlight

Nextpower (NasdaqGS:NXT) has appointed Lindsey Wiedmann as its new Chief Legal and Compliance Officer. Wiedmann steps in following the retirement of Bruce Ledesma from the role. She previously held senior legal and compliance responsibilities at Maxeon Solar Technologies, bringing sector specific experience. For readers tracking NasdaqGS:NXT, this shift in leadership comes at a time when solar and broader clean energy businesses are closely watched for how they handle regulation, policy...
NYSE:ANDG
NYSE:ANDGProfessional Services

Assessing Andersen Group (ANDG) Valuation After Strong Recent Share Price Momentum

Event context and recent share performance Andersen Group (ANDG) recently drew investor interest after a session that left the stock at $35.98, with single day and past week returns of 2.27% and 1.70% respectively. Over the past month and past 3 months, Andersen Group has delivered returns of 25.58% and 67.97%, while year to date the stock shows a 47.58% total return. See our latest analysis for Andersen Group. For context, Andersen Group's recent 1 month share price return of 25.58% and 3...
NasdaqGS:BEAM
NasdaqGS:BEAMBiotechs

A Look At Beam Therapeutics (BEAM) Valuation After Earnings Beat And Positive Clinical Updates

Beam Therapeutics earnings and clinical updates reshape investor focus Beam Therapeutics (BEAM) stock has been in focus after first quarter results showed a net loss of US$94.32 million and a basic loss per share of US$0.91, alongside revenue that exceeded consensus estimates. See our latest analysis for Beam Therapeutics. The latest earnings beat on revenue and a string of encouraging clinical updates have come alongside strong recent momentum, with a 28.50% 1 month share price return and...
NYSE:SARO
NYSE:SAROAerospace & Defense

StandardAero (SARO) Net Margin Reset Challenges Bearish Cash Flow Narratives

StandardAero (SARO) has wrapped up FY 2025 with fourth quarter revenue of US$1.6b and basic EPS of US$0.24, supported by trailing 12 month revenue of US$6.1b and EPS of US$0.84 that sit against a very large reported earnings expansion over the past year. The company has seen quarterly revenue move from US$1.41b in Q4 2024 to US$1.60b in Q4 2025, while basic EPS shifted from a loss of US$0.04 to a profit of US$0.24 over the same period, with trailing net profit margins now framed against a...
NYSE:IEX
NYSE:IEXMachinery

The Bull Case For IDEX (IEX) Could Change Following Strong Q1 Results And 126th Straight Dividend

IDEX Corporation previously announced that its Board approved a regular quarterly cash dividend of US$0.73 per share, payable June 5, 2026 to shareholders of record on May 22, 2026, while also reporting first‑quarter 2026 sales of US$886.9 million and net income of US$120 million. This combination of higher quarterly earnings and the company’s 126th consecutive regular dividend, alongside continued share repurchases, underscores a consistent focus on shareholder returns. We’ll now explore...
NYSE:ULS
NYSE:ULSProfessional Services

UL Solutions (ULS) Is Up 9.9% After Q1 Beat And Hydrogen Safety Push Has The Bull Case Changed?

In early May 2026, UL Solutions Inc. reported first-quarter sales of US$758 million and net income of US$92 million, while also launching new UL Type Examination Certification services for hydrogen fueling station valves and dispenser hoses aligned with ISO 19880-3 and ISO 19880-5 standards. By expanding into hydrogen infrastructure safety testing alongside existing global facilities, UL Solutions is deepening its role as an independent gatekeeper for complex, safety-critical technologies...
NasdaqGS:DBX
NasdaqGS:DBXSoftware

Dropbox (DBX) Net Margin Near 20% Tests Bearish Earnings Decline Narrative

Dropbox (DBX) has wrapped up FY 2025 with fourth quarter revenue of US$636.2 million and basic EPS of US$0.43, alongside trailing 12 month revenue of about US$2.5 billion and EPS of US$1.89 that frame the full year picture. Over the past six quarters in the data provided, quarterly revenue has moved between US$624.7 million and US$643.6 million, while basic EPS has ranged from US$0.34 to US$0.52, giving you a clear view of how the top line and per share earnings have tracked together. For...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

A Look At Upstart Holdings (UPST) Valuation After Q1 2026 Losses And Ongoing Class Action Overhang

Upstart Holdings (UPST) has been back in focus after first quarter 2026 results showed a wider net loss alongside reaffirmed full year revenue guidance, while multiple securities class actions continue to hang over its AI lending model. See our latest analysis for Upstart Holdings. The recent Q1 report, which combined 44% year over year revenue growth with a wider net loss and ongoing class action headlines, has kept pressure on sentiment. This is reflected in a 36.74% year to date share...
NYSE:PBH
NYSE:PBHPharmaceuticals

Has Prestige Consumer Healthcare (PBH) Fallen Too Far After Its 37% One-Year Share Price Drop?

If you are wondering whether Prestige Consumer Healthcare is attractively priced or just a value trap, the stock's recent performance and fundamentals give you plenty to weigh up. The share price recently closed at US$54.59, with returns of a 3.1% decline over 7 days, a 1.9% decline over 30 days, a 10.8% decline year to date, and a 37.3% decline over the last year, while the 3 year and 5 year returns stand at a 6.4% decline and 12.3% respectively. Recent coverage has focused on Prestige...
NYSE:KRG
NYSE:KRGRetail REITs

Kite Realty Group Trust (KRG) Valuation Check After Softer Q1 2026 Earnings And New Guidance

Earnings update and what it means for Kite Realty Group Trust (KRG) Kite Realty Group Trust (KRG) has drawn fresh attention after reporting first quarter 2026 results that showed lower sales, revenue, and net income than a year earlier, alongside new full year earnings guidance. See our latest analysis for Kite Realty Group Trust. Despite softer first quarter earnings, investors have recently bid Kite Realty Group Trust higher, with a 7.4% 90 day share price return and 12.2% year to date...
NasdaqGS:ON
NasdaqGS:ONSemiconductor

Evaluating ON Semiconductor’s Valuation After A Strong 30 Day Share Price Run

Recent performance snapshot ON Semiconductor (ON) has drawn fresh attention after a strong run in its stock price over the month and past 3 months, while also posting annual revenue of US$6.06b and net income of US$573.7m. See our latest analysis for ON Semiconductor. That recent surge in momentum is set against a mixed backdrop, with the 1 day share price return of 4.90% and 7 day share price return of 0.23% sitting alongside a 30 day share price return of 57.68% and 1 year total shareholder...
NYSE:NVT
NYSE:NVTElectrical

A Look At nVent Electric (NVT) Valuation After AI Data Center Driven Earnings Beat And Guidance Raise

nVent Electric (NVT) is back in focus after first quarter earnings comfortably beat analyst expectations, prompting the company to lift its guidance and drawing attention to AI data center driven demand and a growing backlog. See our latest analysis for nVent Electric. The share price has surged recently, with a 7 day share price return of 16.68% and a 30 day share price return of 40.20%. The 1 year total shareholder return is very large, suggesting momentum has been building around the AI...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

Assessing United Therapeutics (UTHR) Valuation After A Strong Year Of Shareholder Returns

Recent performance snapshot United Therapeutics (UTHR) has drawn attention after a strong past year, with a 1-year total return of 84.8% and a 3-month return of 17.3%. This has prompted closer scrutiny of its current valuation and fundamentals. See our latest analysis for United Therapeutics. The recent 1-day share price return of a 4.6% decline sits against a 90-day share price return of 17.3% and a 1-year total shareholder return of 84.8%. This suggests momentum has been building over a...